Drugs Approved for Skin Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer, including drugs for basal cell carcinoma, melanoma, and merkel cell carcinoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in skin cancer that are not listed here.
Drugs Approved for Basal Cell Carcinoma
Drugs Approved for Cutaneous Squamous Cell Carcinoma
Drugs Approved for Melanoma
- Aldesleukin
- Binimetinib
- Braftovi (Encorafenib)
- Cobimetinib
- Cotellic (Cobimetinib)
- Dabrafenib
- Dacarbazine
- DTIC-Dome (Dacarbazine)
- Encorafenib
- IL-2 (Aldesleukin)
- Imlygic (Talimogene Laherparepvec)
- Interleukin-2 (Aldesleukin)
- Intron A (Recombinant Interferon Alfa-2b)
- Ipilimumab
- Keytruda (Pembrolizumab)
- Kimmtrak (Tebentafusp-tebn)
- Mekinist (Trametinib Dimethyl Sulfoxide)
- Mektovi (Binimetinib)
- Nivolumab
- Nivolumab and Relatlimab-rmbw
- Opdivo (Nivolumab)
- Opdualag (Nivolumab and Relatlimab-rmbw)
- Peginterferon Alfa-2b
- Pembrolizumab
- Proleukin (Aldesleukin)
- Recombinant Interferon Alfa-2b
- Sylatron (Peginterferon Alfa-2b)
- Tafinlar (Dabrafenib)
- Talimogene Laherparepvec
- Tebentafusp-tebn
- Trametinib Dimethyl Sulfoxide
- Vemurafenib
- Yervoy (Ipilimumab)
- Zelboraf (Vemurafenib)